Objective
Influenza is one of the most common viral infectious diseases and a significant source of incidence and deaths in numerous regions of the world. The influenza virus, thanks to its adaptation capacities, is one of the most dangerous pathogens in the world. According to the World Health Organization estimations, each year 330 m to 1,575 bn people contract influenza, 3 to 5 m of them suffer from acute symptoms, and 500 thousand to 1 m people die.
Despite the growing importance of diagnostics offered by the modern medicine and greater diagnostic possibilities, the need to create an inexpensive and user-friendly test to detect the influenza virus, with a high-sensitivity and a result ready within a few minutes, has not been fulfilled yet.
Project Leader, Dawid Nidzworski, PhD, a young Polish scientist has proven, within the framework of a grant from the Foundation for Polish Science – VENTURES FNP, that it is possible to develop an innovative biosensor to detect all serotypes of the influenza virus.
For his discovery, he received: The Award of the Minister of Science and Higher Education for international achievements in inventions in 2013 and the Gold Medal with honours at the International Warsaw Invention Show in Warsaw – IWIS 2013, to name just a few.
The results obtained from laboratory tests, which indicate the sensitivity of the biosensor comparable to the molecular methods and a short time of analysis, are a starting point for research and development leading to the Subject of the Project – the development of the prototype of FLUSENSOR, a micro, ultra-sensitive and ultra-fast test to detect all serotypes of the influenza virus.
As part of the Project, an application for reading the result on mobile devices and software to collect and analyse data from the readers and mobile devices will be developed. This means that the solution will be the first comprehensive system in the world to monitor influenza in real-time and simulate its progress world-wide.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences biological sciences microbiology virology
- medical and health sciences health sciences public health epidemiology pandemics
- medical and health sciences health sciences infectious diseases RNA viruses influenza
- medical and health sciences basic medicine pharmacology and pharmacy pharmaceutical drugs antibiotics
- medical and health sciences clinical medicine oncology
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.2.1.4. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
SME-1 - SME instrument phase 1
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-SMEInst-2016-2017
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
02 676 WARSZAWA
Poland
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.